The global genomics and proteomics market is expected to experience a growth in revenues at a CAGR of 12.1% during the forecast period, mainly due to exponential growth in preclinical and clinical research in drug discovery and disease identification. Since global incidence rates of cancer, diabetes and genetic diseases are on a rise, the market revenue growth is inevitable. Moreover, other emerging applications such as forensics and agriculture are also contributing to the growth which in turn has increased the number of research projects all over the world particularly in genomics. Proteomics has grown with increasing interest in protein mutations due to changes in genome and has given rise to a unique field of proteogenomics which is carving a commercial position for itself.
Genomics and proteomics reached a major milestone after the completion of Human Genome project in 2001. During the process, the research industry realized the need for affordable methods to sequence genomes of other organisms as well. This led to a revolution in life science analytical research tools and technologies such as thermal cyclers, mass spectrometry, and gel electrophoresis. An impressive genome database of various organisms is available today for researchers through various sources such as gene banks. Advancing technology and miniaturization of memory devices in electronics and semiconductors has also played a very significant role in creating this accomplishment. Several rare and unknown diseases such as autism, Alzheimer's along with high incidence diseases such as cancer and diabetes are currently being addressed through these technologies by drug discovery, disease identification and structural dynamics of proteins.
A
large fragmented market indicates high competitive pricing and no
loss in quality of products, thus buyers have multiple options to
choose from. Unique software for each application and company
specified reagents for machines have reduced the negotiating power of
buyers as companies do not guarantee good results without usage of
company recommended reagents or software solutions. Customer loyalty
is very low as researchers are keen to experiment with different
products that may yield better results. A high number of acquisitions
and mergers in the field of biotechnology indicate the nature of the
market. New technological innovations are taking place on a regular
basis. Patenting these products and commercializing them is a
challenging task for new entrants in the face of giants such as
Agilent, Thermo-Scientific, Waters and other players. Thus joint
ventures and collaborations with existing players give an excellent
platform for new entrants to expand in this field. The threat of new
entrants is high and is expected to remain so throughout the forecast
period.
Key players leading the genomics and proteomics market are Thermo Fisher Scientific, Agilent Technologies, Life Technologies, Qiagen and Illumina. Intense competition has lowered prices for all types of technologies and is expected to continue further. Miniaturization of technologies such as lab-on-a-chip, biochip and microarray lead the research along with miniaturization of other analytical instruments such as portable mass spectrometers and thermal cyclers.
North America was the largest regional market by revenue in 2012, due to regular break-through innovations in technology that have been introduced in several genomic and proteomic areas. Continued investment in healthcare and medical research is another factor responsible for steady growth in North America. Asia-Pacific and Latin America are expected to show the fastest growth through the forecast period.
The
global genomics and proteomics market is segmented into the following
categories:
Genomics
and Proteomics Market, by Reagent and Research Kits
Sample
Preparation Kits
Prepackaged
Sample Preparation Kits for PCR
Prepackaged
Sample Preparation Kits for Chromatography
Prepackaged Sample Preparation Kits for Mass Spectrometry
Prepackaged Sample Preparation Kits for Electrophoresis
Purification Kits
Electrophoresis Kits
Capillary Electrophoresis
Gel Electrophoresis
BioChips and Microarrays
DNA BioChips and Microarrays
Protein and Peptide BioChips and Microarrays
Genomics and Proteomics Market, by Analytical Instruments
Chromatography
Gas Chromatography
Liquid Chromatography
Mass Spectrometry, by Analyzers
Tandem Mass Spectrometry
Time-Of-Flight Mass Spectrometry
Quadrupole Mass Spectrometry
Fourier Transform Mass Spectrometry
Others (Magnetic Sector, Orbitrap, Ion Trap)
Thermal Cyclers
Digital Thermal Cyclers
Conventional or Traditional Thermal Cyclers
Real-Time Thermal Cyclers
Next Generation Sequencing
Genomics and Proteomics Market, by Geography
North America
Europe
Asia-Pacific
Rest
of the World (RoW)
For Sample Report Visit On:
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
No comments:
Post a Comment